Benznidazole - Chemo group

Drug Profile

Benznidazole - Chemo group

Latest Information Update: 09 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chemo Group
  • Developer Chemo Group; Drugs for Neglected Diseases Initiative Foundation; Mundo Sano
  • Class Acetamides; Antiprotozoals; Imidazoles
  • Mechanism of Action Free radical stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Chagas disease
  • New Molecular Entity No

Highest Development Phases

  • Registered Chagas disease

Most Recent Events

  • 01 Sep 2017 Chemical structure information added
  • 29 Aug 2017 Benznidazole receives tropical disease priority review voucher for Chagas's disease from the US FDA
  • 29 Aug 2017 Registered for Chagas' disease (In children) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top